Mallinckrodt Plc (MNKKQ) Return on Assets ROA from the third quarter of 2026 to third quarter of 2022 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Jun 16 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mallinckrodt Plc  (MNKKQ)


Mallinckrodt Plc's ROA from the third quarter of 2026 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mallinckrodt Plc's ROA in the third quarter of 2026?
Mallinckrodt Plc achieved a return on average assets (ROA) of 5.67 % in its third quarter of 2026, this is above MNKKQ's average return on assets of -4.49%.
Mallinckrodt Plcs assets during the 12 months ending in the third quarter of 2026 are valued at $5 billion

ROA has improved compared to 3.23% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 347 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3933, from total ROA ranking in the second quarter of 2026 at 4189.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Jun 27 2025)
II. Quarter		 (Dec 27 2024)
IV. Quarter		 (Jun 16 2022)
II. Quarter
Y / Y Total Assets Change -44.54 % -40.27 % -64.12 % -18.41 % -7.75 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 299 201 302 96 -781
Return On Assets (TTM) 5.67 % 3.23 % 4.24 % 1.11 % -8.65 %
MNKKQ's Total Ranking # 3933 # 4189 # 3419 # 3100 # 3480
Total Assets (TTM) in million 4,828 5,325 3,286 7,618 8,705
Seq. Total Assets Change -9.35 % 62.05 % -56.86 % -12.49 % -2.37 %
Seq. Net Income Change - - -99.61 % - -

MNKKQ's 5 Years Annual ROA >> Back to MNKKQ Management Effectiveness >> Compare MNKKQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 117
Sector # 348
Overall # 3882

Return On Assets Statistics
High Average Low
14.4 %
-4.49 %
-33.88 %
(Dec 29 2017)   (Sep 27 2019)





Financial Statements
Mallinckrodt Plc's Assets $ 4,828 million MNKKQ's Balance sheet
Mallinckrodt Plc's Income $ -96 million Quarterly MNKKQ's Income Statement
MNKKQ's Income by Division See MNKKQ's Income by Division



Annual Return On Assets (Dec 27 2024)
FY 2024		 (Dec 31 2021)
FY 2021		 (Dec 25 2020)
FY 2020		 (Dec 27 2019)
FY 2019		 (Dec 28 2018)
FY 2018
Y / Y Total Assets Change 27.56 % -8.23 % -6.03 % -4.95 % -28.82 %
Total Assets in million 11,374 8,916 9,715 10,339 10,877
Y / Y Net Income Change - - - - -
Net Income in million 478 -717 -945 -997 -3,607
Annual Return On Assets 4.2 % -8.05 % -9.72 % -9.64 % -33.16 %

MNKKQ's 5 Years Annual ROA >> Back to MNKKQ Management Effectiveness >> Compare MNKKQ ROA to its Competitors



Comment on MNKKQ's ROA in the fiscal year ending 2024
In the fiscal year 2024 ROA improved to 4.2 % compared to prior year, due to annual net income growth of % to $477.90 million, while value of Mallinckrodt Plc's overall assets grew just by 27.56 % to $11,373.80 million, compared to $11,373.80 a year before.


More Return On Assets Ratios
MNKKQ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MNKKQ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MNKKQ's Competitors
Subscribers only: Roa for Mallinckrodt Plc's Suppliers
Subscribers only: Return On Assets for MNKKQ's Customers

You may also want to know
MNKKQ's Roi MNKKQ's Inventory Turnover Ratio MNKKQ's Growth Rates MNKKQ's Dividend Comparisons
MNKKQ's Profitability Ratios MNKKQ's Asset Turnover Ratio MNKKQ's Dividend Growth
MNKKQ's Roe MNKKQ's Valuation Ratios MNKKQ's Financial Strength Ratios MNKKQ's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Alpha Pro Tech Ltd   12.46 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Sanuwave Health Inc   9.05 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %

Date modified: 2026-11-12T05:51:55+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.